IQ EQ Fund Management’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-15,240
| Closed | -$115K | – | 220 |
|
|
2022
Q2 | $115K | Buy |
15,240
+730
| +5% | +$5.51K | 0.02% | 188 |
|
|
2022
Q1 | $231K | Buy |
14,510
+3,888
| +37% | +$61.9K | 0.04% | 180 |
|
|
2021
Q4 | $196K | Buy |
10,622
+968
| +10% | +$17.9K | 0.03% | 207 |
|
|
2021
Q3 | $295K | Sell |
9,654
-86,488
| -90% | -$2.64M | 0.05% | 227 |
|
|
2021
Q2 | $5.28M | Buy |
96,142
+24,074
| +33% | +$1.32M | 0.81% | 34 |
|
|
2021
Q1 | $4.26M | Buy |
72,068
+70,170
| +3,697% | +$4.15M | 0.75% | 31 |
|
|
2020
Q4 | $71K | Buy |
1,898
+1,068
| +129% | +$40K | 0.02% | 226 |
|
|
2020
Q3 | $45K | Buy |
830
+282
| +51% | +$15.3K | 0.01% | 193 |
|
|
2020
Q2 | $138K | Buy |
548
+181
| +49% | +$45.6K | 0.05% | 183 |
|
|
2020
Q1 | $58K | Buy |
+367
| New | +$58K | 0.02% | 137 |
|